| |
|
|
|
Cleveland BioLabs Inc.  
|
|
1.81 0.08 (0.05%) |
11-19 15:24 |
|
Open: |
1.8 |
Pre close: |
1.73 |
Target:
|
2.18 
|
|
High: |
1.81 |
Low: |
1.6951 |
Resistance:
|
1.87
2.18
|
|
Volume: |
4,047 |
Market Cap: |
20M |
Support:
|
1.67
1.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.73
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.70 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.02 |
Stochastic Oscillator |
%K(14,3):
|
69.68 |
|
MA(250): |
2.69 |
%D(3): |
60.38 |
|
Average Volume(K) |
3-Month: |
629
|
52-Week |
High:
|
4.25 |
|
10-Days: |
384 |
Low: |
1.54 |
|
RSI |
RSI(14):
|
55.17 |
Change(%): |
-28.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-190.2 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-46.7 |
Shares Float (M) |
7.64 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
89.9 |
% Held by Institutions |
6.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
149.600 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.99 |
P/S |
127831240.00 |
|
Operating Margin |
-297.53 |
Levered Free Cash Flow
(M) |
-3.64 |
P/CF |
-4.10 |
|
|
|
|
|
|
